Essex Woodlands Management, Inc.

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 6Value: $346.7MLatest: 2025Q1

Essex Woodlands Management, Inc. is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 6 holdings worth $0.3 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MNOV",
  "MDXG",
  "TELA",
  "VERO",
  "EYPT",
  "BVS"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-13
Total Holdings: 6
Total Value: 346675640
Accession Number: 0000908834-25-000169
Form Type: 13F-HR
CIK: essex-woodlands-management
Manager Name: Essex-Woodlands-Management

Data Enrichment

100% identified

6 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

6 positions • $346.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

MIMEDX GROUP, INC.

MDXG|602496101

Shares:28.2M

Value:$214.3M

% of Portfolio:61.8% ($214.3M/$346.7M)

Bioventus Inc.

BVS|09075A108

Shares:13.0M

Value:$119.1M

% of Portfolio:34.4% ($119.1M/$346.7M)

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

Shares:1.2M

Value:$6.3M

% of Portfolio:1.8% ($6.3M/$346.7M)

TELA Bio, Inc.

TELA|872381108

Shares:4.1M

Value:$5.0M

% of Portfolio:1.4% ($5.0M/$346.7M)

MEDICINOVA INC

MNOV|58468P206

Shares:1.1M

Value:$1.6M

% of Portfolio:0.5% ($1.6M/$346.7M)

Venus Concept Inc.

VERO|92332W303

Shares:99.0K

Value:$276.3K

% of Portfolio:0.1% ($276.3K/$346.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
MIMEDX GROUP, INC.(MDXGcusip602496101)	28.2M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$214.3M	61.8% ($214.3M/$346.7M)	QoQ -20.99% (-$57.0M) YoY -1.29% (-$2.8M)
Bioventus Inc.(BVScusip09075A108)	13.0M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$119.1M	34.4% ($119.1M/$346.7M)	QoQ -12.85% (-$17.6M) YoY +75.96% (+$51.4M)
EyePoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	1.2M	QoQ 0.00% (-0) YoY -24.59% (-381.7K)	All Managers (Combined)	$6.3M	1.8% ($6.3M/$346.7M)	QoQ -27.24% (-$2.4M) YoY -80.22% (-$25.7M)
TELA Bio, Inc.(TELAcusip872381108)	4.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.0M	1.4% ($5.0M/$346.7M)	QoQ -59.60% (-$7.4M) YoY -78.48% (-$18.3M)
MEDICINOVA INC(MNOVcusip58468P206)	1.1M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$1.6M	0.5% ($1.6M/$346.7M)	QoQ -30.47% (-$707.8K) YoY +0.68% (+$11.1K)
Venus Concept Inc.(VEROcusip92332W303)	99.0K	QoQ NEW(+99.0K) YoY NEW(+99.0K)	All Managers (Combined)	$276.3K	0.1% ($276.3K/$346.7M)	QoQ NEW(+$276.3K) YoY NEW(+$276.3K)